Stephanie M Engel

Dr. Stephanie M Engel


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Environmental Health Perspectives
Verified
Journal Article
Open access
SEStephanie M Engel
Stephanie M Engel
JWJames Wetmur
James Wetmur
JCJia Chen
Jia Chen
CZChenbo Zhu
Chenbo Zhu
Dana Boyd BarrDana Boyd Barr
Dana Boyd Barr
MWMary S. Wolff
Mary S. Wolff
Background: Prenatal exposure to organophosphate pesticides has been shown to negatively affect child neurobehavioral development. Paraoxonase 1 (PON1) is a key enzyme in the metabolism of organophosphates.Objective: We examined the relationship between biomarkers of organophosphate exposure, PON1, and cognitive development at ages 12 and 24 months and 6–9 years.Methods: The Mount Sinai Children’s Environmental Health Study enrolled a multiethnic prenatal population in New York City between 1998 and 2002 (n = 404). Third-trimester maternal urine samples were collected and analyzed for organophosphate metabolites (n = 360). Prenatal maternal blood was analyzed for PON1 activity and genotype. Children returned for neurodevelopment assessments ages 12 months (n = 200), 24 months (n = 276), and 6–9 (n = 169) years of age.Results: Prenatal total dialkylphosphate metabolite level was associated with a decrement in mental development at 12 months among blacks and Hispanics. These associations appeared to be enha...

24 December 2011 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
TKThomas A. Kraus
Thomas A. Kraus
SEStephanie M Engel
Stephanie M Engel
RSRhoda Mount Sperling
Rhoda Mount Sperling
LKLisa Kellerman
Lisa Kellerman
YLYungtai Lo
Yungtai Lo
TMThomas M. Moran
Thomas M. Moran

21 May 2018 in Environmental Health Perspectives
Verified
Journal Article
Closed access
SEStephanie M Engel
Stephanie M Engel
GVGro D. Villanger
Gro D. Villanger
RNRachel C. Nethery
Rachel C. Nethery
CTCathrine Thomsen
Cathrine Thomsen
ASAmrit K. Sakhi
Amrit K. Sakhi
HAHeidi Aase
Heidi Aase

20 February 2014 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SEStephanie M Engel
Stephanie M Engel
BJBonnie Joubert
Bonnie Joubert
MWMichael C. Wu
Michael C. Wu
AOAndrew F. Olshan
Andrew F. Olshan
SHSiri E. Håberg
Siri E. Håberg
SLStephanie London
Stephanie London
Although epigenetic regulation plays a critical role in embryonic development, few studies have examined the relationship of epigenome-wide methylation with fetal growth. Using the Infinium HumanMethylation450 BeadChip (Illumina, Inc., San Diego, California) in a substudy of 1,046 infants from the Norwegian Mother and Child Cohort Study (MoBa) enrolled between 1999 and 2008, we examined epigenome-wide cord blood DNA methylation in relation to birth weight. In multivariable-adjusted robust linear regression models, we identified differential methylation at 19 cytosine-guanine dinucleotides (CpGs) associated with either decreased (AT-rich interactive domain 5B (MRF1-like) (ARID5B), 2 CpGs) or increased (x-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3), 4 CpGs) birth weight. ARID5B knockout mice have less adipose tissue and significantly lower weight in the postnatal period. XRCC3 plays a key role in the maintenance of chromosome stability and the repair of DNA damage. Although there are fewer data on the other implicated genes, many of these genes have been shown to have roles in developmental processes. This constitutes the largest and most robust study of birth weight using an epigenome-wide methylation platform and offers potential insights into epigenetic mechanisms of fetal growth.

1 April 2021 in American Journal of Public Health
Verified
Journal Article
Closed access
SEStephanie M Engel
Stephanie M Engel
HPHeather B. Patisaul
Heather B. Patisaul
CBCharlotte Brody
Charlotte Brody
RHRuss Hauser
Russ Hauser
AZAmi R. Zota
Ami R. Zota
RWRobin M. Whyatt
Robin M. Whyatt
Robust data from longitudinal birth cohort studies and experimental studies of perinatally exposed animals indicate that exposure to ortho-phthalates can impair brain development and increase risks for learning, attention, and behavioral disorders in childhood. This growing body of evidence, along with known adverse effects on male reproductive tract development, calls for immediate action. Exposures are ubiquitous; the majority of people are exposed to multiple ortho-phthalates simultaneously. We thus recommend that a class approach be used in assessing health impacts as has been done with other chemical classes. We propose critically needed policy reforms to eliminate ortho-phthalates from products that lead to exposure of pregnant women, women of reproductive age, infants, and children. Specific attention should be focused on reducing exposures among socially vulnerable populations such as communities of color, who frequently experience higher exposures. Ortho-phthalates are used in a vast array of products and elimination will thus necessitate a multipronged regulatory approach at federal and state levels. The fact that manufacturers and retailers have already voluntarily removed ortho-phthalates from a wide range of products indicates that this goal is feasible.

1 June 2016 in Environmental Health Perspectives
Verified
Journal Article
Open access
SEStephanie M Engel
Stephanie M Engel
ABAsa Bradman
Asa Bradman
MWMary S. Wolff
Mary S. Wolff
VRVirginia A. Rauh
Virginia A. Rauh
KHKim G. Harley
Kim G. Harley
BEBrenda Eskenazi
Brenda Eskenazi
Background: Organophosphorus pesticides (OPs) are used in agriculture worldwide. Residential use was common in the United States before 2001. Objectives: We conducted a pooled analysis of four birth cohorts (children’s centers; n = 936) to evaluate associations of prenatal exposure to OPs with child development at 24 months. Methods: Using general linear models, we computed site-specific and pooled estimates of the association of total dialkyl (ΣDAP), diethyl (ΣDEP), and dimethylphosphate (ΣDMP) metabolite concentrations in maternal prenatal urine with mental and psychomotor development indices (MDI/PDI) and evaluated heterogeneity by children’s center, race/ethnicity, and PON1 genotype. Results: There was significant heterogeneity in the center-specific estimates of association for ΣDAP and ΣDMP and the MDI (p = 0.09, and p = 0.05, respectively), as well as heterogeneity in the race/ethnicity-specific estimates for ΣDAP (p = 0.06) and ΣDMP (p = 0.02) and the MDI. Strong MDI associations in the CHAMACOS population per 10-fold increase in ΣDAP (β = –4.17; 95% CI: –7.00, –1.33) and ΣDMP (β = –3.64; 95% CI: –5.97, –1.32) were influential, as were associations among Hispanics (β per 10-fold increase in ΣDAP = –2.91; 95% CI: –4.71, –1.12). We generally found stronger negative associations of ΣDAP and ΣDEP with the 24-month MDI for carriers of the 192Q PON1 allele, particularly among blacks and Hispanics. Conclusions: Data pooling was complicated by center-related differences in subject characteristics, eligibility, and changes in regulations governing residential use of OPs during the study periods. Pooled summary estimates of prenatal exposure to OPs and neurodevelopment should be interpreted with caution because of significant heterogeneity in associations by center, race/ethnicity, and PON1 genotype. Subgroups with unique exposure profiles or susceptibilities may be at higher risk for adverse neurodevelopment following prenatal exposure. Citation: Engel SM, Bradman A, Wolff MS, Rauh VA, Harley KG, Yang JH, Hoepner LA, Barr DB, Yolton K, Vedar MG, Xu Y, Hornung RW, Wetmur JG, Chen J, Holland NT, Perera FP, Whyatt RM, Lanphear BP, Eskenazi B. 2016. Prenatal organophosphorus pesticide exposure and child neurodevelopment at 24 months: an analysis of four birth cohorts. Environ Health Perspect 124:822–830; http://dx.doi.org/10.1289/ehp.1409474